Recently, NACDS provided a summary of the 2014 midterm elections, with an emphasis on the federal level. This memo includes an overview of the state elections, which will shape the operating environment on pivotal state issues.
Michael Taylor, who currently serves as the Food and Drug Administration's deputy commissioner for foods and veterinary medicine, outlined the importance for companies to adhere to gluten-free guidelines in a post on FDA Voice.
The Food and Drug Administration on Thursday proposed to update the Nutrition Facts label for packaged foods to reflect the latest scientific information, including the link between diet and such chronic diseases as obesity and heart disease.
In a blog post updated Friday, Food and Drug Administration commissioner Margaret Hamburg addressed two challenges facing Indian drug manufacturers — approval times for abbreviated new drug applications and quality inspections.
The Food and Drug Administration launched the advisory committee membership nomination portal, an online, interactive system that allows interested individuals to submit nominations for membership to any of the agency’s 33 advisory committees.
L’Oréal USA honored the recipients of the 2013 L’Oréal USA Fellowships For Women in Science at an awards ceremony Thursday evening. Celebrating its 10th year, the program is a national initiative that annually recognizes and rewards five U.S.-based post-doctoral women researchers.
Johnson & Johnson on Monday announced that Mark McClellan, senior fellow in economic studies and director of the Initiative on Value and Innovation in Health Care at the Brookings Institution, will join the company's board of directors on Oct. 15. McClellan will serve on the regulatory, compliance and government affairs committee, as well as the science, technology and sustainability committee.
Changes in healthcare delivery today are influencing the way community pharmacy serves patients. That was the key message healthcare policy wizard Mark McClellan, M.P.A., M.D., PhD., had for attendees of an Aug. 9 industry general session in Seattle at Cardinal Health's annual Retail Business Conference.
Healthcare policy wizard Mark McClellan, M.P.A., M.D., PhD., will deliver the industry session on Friday, Aug. 9 at Cardinal Health's annual Retail Business Conference. Titled "Driving the Conversation: A Look at the Future of Healthcare in America," the former administrator of the Centers for Medicare and Medicaid Services and commissioner of the Food and Drug Administration, will focus on the crucial role community pharmacy will play in shaping that future.
One of the difficulties that federal regulators ran into during the nationwide scandal surrounding the New England Compounding Center — the Massachusetts-based pharmacy blamed for a nationwide fungal meningitis epidemic that has sickened hundreds and killed dozens — was the issue of when such pharmacies cross the line from compounding to manufacturing.
Food and Drug Administration commissioner Margaret Hamburg faced strong criticism Tuesday in a hearing before the House Committee on Energy and Commerce to investigate the nationwide outbreak of fungal meningitis linked to a Massachusetts compounding pharmacy, but she conceded the agency could have done more.
An inspection of more than two-dozen compounding pharmacies by Food and Drug Administration officials has found widespread problems with sanitation and sterilization practices, FDA commissioner Margaret Hamburg wrote in a blog post on the agency's website Thursday.
The Food and Drug Administration has 30 days to approve over-the-counter availability of the emergency contraceptive Plan B One-Step to women of all ages, according to a decision issued by Judge Edward Korman of the U.S. District Court, Eastern District of New York.
A group of doctors and public health professors are hoping the Food and Drug Administration will place stronger regulations on energy drinks to protect children and adolescents from what they call the harmful effects of high caffeine consumption.
New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.